In humans the repeated use of amphetamine (AMPH) produces a hypersensitivity to the psychotogenic effects of AMPH that persists for months to years after the cessation of drug use. To explore the neurobiological basis of this phenomenon the long-term effects of dextroamphetamine ((+)-AMPH) on brain monoamines and behavior were studied in an animal model of AMPH lbsychosis. An escalating dose pretreatment regimen (from 1 to 10 mg/kg over 5 weeks) was used to mimic the pattern of drug use associated with the development of addiction and AMPH psychosis. The effect of pretreatment with AMPH on dopamine (DA) release in the ventral striaturn (nucleus accumbens) was determined by measuring the extracellular concentrations of DA and DA metabolites using in vivo microdialysis, both before and after an AMPH challenge. The postmortem tissue concentrations of DA, serotonin and their metabolites were measured to determine if this treatment was neurotoxic. Escalating doses of (+)-AMPH were not neurotoxic, and 25-30 days after the cessation of drug treatment animals showed relatively normal levels of spontaneous motor activity across the day-night cycle. However, AMPH pretreatment produced robust behavioral sensitization. Animals showed a marked hypersensitivity to the motor stimulant effects of an AMPH challenge, even after 15-20 days of withdrawal. Most importantly, this hyperdopaminergic behavioral syndrome was accompanied by significantly elevated DA release in the ventral striatum. In contrast, AMPH pretreatment had no effect on the ~oasal extracellular concentrations of DA. It is suggested that the sensitization produced by chronic AMPH use is due to enduring changes in the releasability of DA, and that this may represent an example of neural plasticity common to other forms of behavioral adaptation.
INTRODUCTION
People who abuse psychomotor stimulant drugs, such as amphetamine (AMPH) or cocaine, frequently develop a drug-induced paranoid psychotic condition characterized by delusions of persecution, hallucinations, affective disturbances and perseverative behavior 6'9'4°. AMPH psychosis usually dissipates upon the cessation of drug use, but there are also long-term sequelae associated with AMPH abuse. For example, re-exposure to a relatively low dose of AMPH will often precipitate a psychotic episode in former AMPH addicts who have been abstinent for months to years 35'36,46. The enduring hypersensitivity to AMPH seen in former addicts suggests that chronic AMPH use has long-term effects on brain function.
A number of animal models have been developed to study the neurobioiogical consequences of chronic AMPH treatment. For example, AMPH addicts frequently take very high doses of AMPH in 'runs' that can last for 4-6 days 21, and some researchers have attempted to capture this pattern of use by repeatedly administering very high doses of AMPH (~10-20
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